Dunn BM - Search Results

1

Exploring the binding preferences/specificity in the active site of human cathepsin E.

Rao-Naik C, Guruprasad K, Batley B, Rapundalo S, Hill J, Blundell T, Kay J, Dunn BM. Rao-Naik C, et al. Among authors: dunn bm. Proteins. 1995 Jun;22(2):168-81. doi: 10.1002/prot.340220209. Proteins. 1995. PMID: 7567964

2

Structure-function database for active site binding to the aspartic proteinases.

Rao C, Scarborough PE, Lowther WT, Kay J, Batley B, Rapundalo S, Klutchko S, Taylor MD, Dunn BM. Rao C, et al. Among authors: dunn bm. Adv Exp Med Biol. 1991;306:143-7. doi: 10.1007/978-1-4684-6012-4_19. Adv Exp Med Biol. 1991. PMID: 1812702 No abstract available.

3

Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation.

Rao CM, Scarborough PE, Kay J, Batley B, Rapundalo S, Klutchko S, Taylor MD, Lunney EA, Humblet CC, Dunn BM. Rao CM, et al. Among authors: dunn bm. J Med Chem. 1993 Sep 3;36(18):2614-20. doi: 10.1021/jm00070a004. J Med Chem. 1993. PMID: 8410973

4

Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling.

Scarborough PE, Guruprasad K, Topham C, Richo GR, Conner GE, Blundell TL, Dunn BM. Scarborough PE, et al. Among authors: dunn bm. Protein Sci. 1993 Feb;2(2):264-76. doi: 10.1002/pro.5560020215. Protein Sci. 1993. PMID: 8443603 Free PMC article.

5

Comparison of the active site specificity of the aspartic proteinases based on a systematic series of peptide substrates.

Dunn BM, Scarborough PE, Lowther WT, Rao-Naik C. Dunn BM, et al. Adv Exp Med Biol. 1995;362:1-9. doi: 10.1007/978-1-4615-1871-6_1. Adv Exp Med Biol. 1995. PMID: 8540305 No abstract available.

6

Detailed analysis of human cathepsin E prime region specificity.

Bukhtiyarova M, Rao-Naik C, Tatnell PJ, White PC, Kay J, Dunn BM. Bukhtiyarova M, et al. Among authors: dunn bm. Adv Exp Med Biol. 1998;436:219-22. doi: 10.1007/978-1-4615-5373-1_31. Adv Exp Med Biol. 1998. PMID: 9561223 No abstract available.

7

Substrate specificity and inhibitors of aspartic proteinases.

Kay J, Dunn BM. Kay J, et al. Among authors: dunn bm. Scand J Clin Lab Invest Suppl. 1992;210:23-30. Scand J Clin Lab Invest Suppl. 1992. PMID: 1455176 Review.

8

Comparison of kinetic properties of native and recombinant human cathepsin D.

Scarborough PE, Richo GR, Kay J, Conner GE, Dunn BM. Scarborough PE, et al. Among authors: dunn bm. Adv Exp Med Biol. 1991;306:343-7. doi: 10.1007/978-1-4684-6012-4_41. Adv Exp Med Biol. 1991. PMID: 1812725 No abstract available.

9

Viral proteinases: weakness in strength.

Kay J, Dunn BM. Kay J, et al. Among authors: dunn bm. Biochim Biophys Acta. 1990 Jan 30;1048(1):1-18. doi: 10.1016/0167-4781(90)90015-t. Biochim Biophys Acta. 1990. PMID: 2404520 Review. No abstract available.

10

Identification of the aspartic proteinases from human erythrocyte membranes and gastric mucosa (slow-moving proteinase) as catalytically equivalent to cathepsin E.

Jupp RA, Richards AD, Kay J, Dunn BM, Wyckoff JB, Samloff IM, Yamamoto K. Jupp RA, et al. Among authors: dunn bm. Biochem J. 1988 Sep 15;254(3):895-8. doi: 10.1042/bj2540895. Biochem J. 1988. PMID: 3058118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page